Algorae taps AI to develop anti-cancer drug combos
Sydney Morning Herald, Other, 21/11/2024, James Pearson
Medical technology innovator Algorae Pharmaceuticals has identified 24 different existing drug combinations put together by a “super-computer” using artificial intelligence that it says could potentially impact some cancers. […] The AI platform was developed in collaboration with the University of NSW AI Institute, supported by funding from CSIRO’s Data61 unit.